Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Asthma

  Free Subscription


Articles published in Respir Res

Retrieve available abstracts of 61 articles:
HTML format
Text format



Single Articles


    July 2018
  1. BARDSLEY G, Daley-Yates P, Baines A, Kempsford R, et al
    Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial.
    Respir Res. 2018;19:133.
    PubMed     Text format     Abstract available


    June 2018
  2. PHILPOTT CM, Erskine S, Hopkins C, Kumar N, et al
    Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study.
    Respir Res. 2018;19:129.
    PubMed     Text format     Abstract available


  3. KHO AT, McGeachie MJ, Moore KG, Sylvia JM, et al
    Circulating microRNAs and prediction of asthma exacerbation in childhood asthma.
    Respir Res. 2018;19:128.
    PubMed     Text format     Abstract available


  4. XIN T, Chen M, Duan L, Xu Y, et al
    Interleukin-32: its role in asthma and potential as a therapeutic agent.
    Respir Res. 2018;19:124.
    PubMed     Text format     Abstract available


  5. MATUCCI A, Vultaggio A, Maggi E, Kasujee I, et al
    Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question?
    Respir Res. 2018;19:113.
    PubMed     Text format     Abstract available


    May 2018
  6. CLOOTS RHE, Poynter ME, Terwindt E, Lamers WH, et al
    Hypoargininemia exacerbates airway hyperresponsiveness in a mouse model of asthma.
    Respir Res. 2018;19:98.
    PubMed     Text format     Abstract available


  7. BELVISI MG, Baker K, Malloy N, Raemdonck K, et al
    Modelling the asthma phenotype: impact of cigarette smoke exposure.
    Respir Res. 2018;19:89.
    PubMed     Text format     Abstract available


    April 2018
  8. BLOECHLIGER M, Reinau D, Spoendlin J, Chang SC, et al
    Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis.
    Respir Res. 2018;19:75.
    PubMed     Text format     Abstract available


    March 2018
  9. WANG J, Lv H, Luo Z, Mou S, et al
    Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD.
    Respir Res. 2018;19:47.
    PubMed     Text format     Abstract available


  10. PADILLA-GALO A, Olveira C, Fernandez de Rota-Garcia L, Marco-Galve I, et al
    Factors associated with bronchiectasis in patients with uncontrolled asthma; the NOPES score: a study in 398 patients.
    Respir Res. 2018;19:43.
    PubMed     Text format     Abstract available


  11. PARK HY, Lee SY, Kang D, Cho J, et al
    Favorable longitudinal change of lung function in patients with asthma-COPD overlap from a COPD cohort.
    Respir Res. 2018;19:36.
    PubMed     Text format     Abstract available


    January 2018
  12. MAHMUTOVIC PERSSON I, Menzel M, Ramu S, Cerps S, et al
    IL-1beta mediates lung neutrophilia and IL-33 expression in a mouse model of viral-induced asthma exacerbation.
    Respir Res. 2018;19:16.
    PubMed     Text format     Abstract available


  13. LARSSON K, Stallberg B, Lisspers K, Telg G, et al
    Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR).
    Respir Res. 2018;19:12.
    PubMed     Text format     Abstract available


  14. USMANI OS, Lavorini F, Marshall J, Dunlop WCN, et al
    Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes.
    Respir Res. 2018;19:10.
    PubMed     Text format     Abstract available


    December 2017
  15. BAO A, Yang H, Ji J, Chen Y, et al
    Involvements of p38 MAPK and oxidative stress in the ozone-induced enhancement of AHR and pulmonary inflammation in an allergic asthma model.
    Respir Res. 2017;18:216.
    PubMed     Text format     Abstract available


  16. VARGAS A, Boivin R, Cano P, Murcia Y, et al
    Neutrophil extracellular traps are downregulated by glucocorticosteroids in lungs in an equine model of asthma.
    Respir Res. 2017;18:207.
    PubMed     Text format     Abstract available


  17. KASTELEYN MJ, Bonten TN, de Mutsert R, Thijs W, et al
    Pulmonary function, exhaled nitric oxide and symptoms in asthma patients with obesity: a cross-sectional study.
    Respir Res. 2017;18:205.
    PubMed     Text format     Abstract available


  18. WANG G, Zhang X, Zhang HP, Wang L, et al
    Corticosteroid plus beta2-agonist in a single inhaler as reliever therapy in intermittent and mild asthma: a proof-of-concept systematic review and meta-analysis.
    Respir Res. 2017;18:203.
    PubMed     Text format     Abstract available


    November 2017
  19. LO CY, Michaeloudes C, Bhavsar PK, Huang CD, et al
    Reduced suppressive effect of beta2-adrenoceptor agonist on fibrocyte function in severe asthma.
    Respir Res. 2017;18:194.
    PubMed     Text format     Abstract available


  20. ZHANG L, Zhang J, Gao P
    The potential of interleukin-37 as an effective therapeutic agent in asthma.
    Respir Res. 2017;18:192.
    PubMed     Text format     Abstract available


  21. PEREZ-DE-LLANO L, Cosio BG
    Asthma-COPD overlap is not a homogeneous disorder: further supporting data.
    Respir Res. 2017;18:183.
    PubMed     Text format     Abstract available


    September 2017
  22. TORAIH EA, Hussein MH, Al Ageeli E, Riad E, et al
    Structure and functional impact of seed region variant in MIR-499 gene family in bronchial asthma.
    Respir Res. 2017;18:169.
    PubMed     Text format     Abstract available


    August 2017
  23. SALTER B, Pray C, Radford K, Martin JG, et al
    Regulation of human airway smooth muscle cell migration and relevance to asthma.
    Respir Res. 2017;18:156.
    PubMed     Text format     Abstract available


  24. BLAIS CM, Davis BE, Cockcroft DW
    The effect of glycopyrronium and indacaterol, as monotherapy and in combination, on the methacholine dose-response curve of mild asthmatics: a randomized three-way crossover study.
    Respir Res. 2017;18:146.
    PubMed     Text format     Abstract available


    July 2017
  25. DEMARCHE SF, Schleich FN, Paulus VA, Henket MA, et al
    Is it possible to claim or refute sputum eosinophils >/= 3% in asthmatics with sufficient accuracy using biomarkers?
    Respir Res. 2017;18:133.
    PubMed     Text format     Abstract available


    June 2017
  26. BARRY LE, Sweeney J, O'Neill C, Price D, et al
    The cost of systemic corticosteroid-induced morbidity in severe asthma: a health economic analysis.
    Respir Res. 2017;18:129.
    PubMed     Text format     Abstract available


    May 2017
  27. WEBLEY WC, Hahn DL
    Infection-mediated asthma: etiology, mechanisms and treatment options, with focus on Chlamydia pneumoniae and macrolides.
    Respir Res. 2017;18:98.
    PubMed     Text format     Abstract available


  28. MALMSTROM K, Lohi J, Sajantila A, Jahnsen FL, et al
    Immunohistology and remodeling in fatal pediatric and adolescent asthma.
    Respir Res. 2017;18:94.
    PubMed     Text format     Abstract available


    April 2017
  29. KOLSUM U, Ravi A, Hitchen P, Maddi S, et al
    Clinical characteristics of eosinophilic COPD versus COPD patients with a history of asthma.
    Respir Res. 2017;18:73.
    PubMed     Text format     Abstract available


  30. JUNG KH, Torrone D, Lovinsky-Desir S, Perzanowski M, et al
    Short-term exposure to PM2.5 and vanadium and changes in asthma gene DNA methylation and lung function decrements among urban children.
    Respir Res. 2017;18:63.
    PubMed     Text format     Abstract available


  31. CRUICKSHANK-QUINN C, Armstrong M, Powell R, Gomez J, et al
    Determining the presence of asthma-related molecules and salivary contamination in exhaled breath condensate.
    Respir Res. 2017;18:57.
    PubMed     Text format     Abstract available


  32. BAKER K, Raemdonck K, Snelgrove RJ, Belvisi MG, et al
    Characterisation of a murine model of the late asthmatic response.
    Respir Res. 2017;18:55.
    PubMed     Text format     Abstract available


    March 2017
  33. NATARAJAN S, Free RC, Bradding P, McGarvey L, et al
    The relationship between the Leicester cough questionnaire, eosinophilic airway inflammation and asthma patient related outcomes in severe adult asthma.
    Respir Res. 2017;18:44.
    PubMed     Text format     Abstract available


    February 2017
  34. SEYS SF, Scheers H, Van den Brande P, Marijsse G, et al
    Cluster analysis of sputum cytokine-high profiles reveals diversity in T(h)2-high asthma patients.
    Respir Res. 2017;18:39.
    PubMed     Text format     Abstract available


  35. BOULAY ME, Henry C, Bosse Y, Boulet LP, et al
    Acute effects of nicotine-free and flavour-free electronic cigarette use on lung functions in healthy and asthmatic individuals.
    Respir Res. 2017;18:33.
    PubMed     Text format     Abstract available


    January 2017
  36. MAKIKYRO EM, Jaakkola MS, Jaakkola JJ
    Subtypes of asthma based on asthma control and severity: a latent class analysis.
    Respir Res. 2017;18:24.
    PubMed     Text format     Abstract available


  37. FUJII U, Miyahara N, Taniguchi A, Oda N, et al
    Effect of a retinoid X receptor partial agonist on airway inflammation and hyperresponsiveness in a murine model of asthma.
    Respir Res. 2017;18:23.
    PubMed     Text format     Abstract available


  38. GREEN CE, Turner AM
    The role of the endothelium in asthma and chronic obstructive pulmonary disease (COPD).
    Respir Res. 2017;18:20.
    PubMed     Text format     Abstract available


  39. TAYEL SI, El-Hefnway SM, Abd El Gayed EM, Abdelaal GA, et al
    Association of stem cell factor gene expression with severity and atopic state in patients with bronchial asthma.
    Respir Res. 2017;18:21.
    PubMed     Text format     Abstract available


  40. AUGUSTO LS, Silva GC, Pinho JF, Aires RD, et al
    Vascular function in asthmatic children and adolescents.
    Respir Res. 2017;18:17.
    PubMed     Text format     Abstract available


  41. TOPALOVIC M, Exadaktylos V, Troosters T, Celis G, et al
    Non-linear parameters of specific resistance loops to characterise obstructive airways diseases.
    Respir Res. 2017;18:9.
    PubMed     Text format     Abstract available


  42. KIM SH, Pei QM, Jiang P, Yang M, et al
    Effect of active vitamin D3 on VEGF-induced ADAM33 expression and proliferation in human airway smooth muscle cells: implications for asthma treatment.
    Respir Res. 2017;18:7.
    PubMed     Text format     Abstract available


    December 2016
  43. LOZA MJ, Djukanovic R, Chung KF, Horowitz D, et al
    Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study.
    Respir Res. 2016;17:165.
    PubMed     Text format     Abstract available


  44. SULLIVAN A, Hunt E, MacSharry J, Murphy DM, et al
    'The Microbiome and the Pathophysiology of Asthma'.
    Respir Res. 2016;17:163.
    PubMed     Text format     Abstract available


    November 2016
  45. O'BYRNE PM, Jacques L, Goldfrad C, Kwon N, et al
    Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma.
    Respir Res. 2016;17:157.
    PubMed     Text format     Abstract available


  46. KRAEMER R, Smith HJ, Sigrist T, Giger G, et al
    Diagnostic accuracy of methacholine challenge tests assessing airway hyperreactivity in asthmatic patients - a multifunctional approach.
    Respir Res. 2016;17:154.
    PubMed     Text format     Abstract available


  47. WANG M, Gao P, Wu X, Chen Y, et al
    Impaired anti-inflammatory action of glucocorticoid in neutrophil from patients with steroid-resistant asthma.
    Respir Res. 2016;17:153.
    PubMed     Text format     Abstract available


  48. FRANZEN S, Janson C, Larsson K, Petzold M, et al
    Evaluation of the use of Swedish integrated electronic health records and register health care data as support clinical trials in severe asthma: the PACEHR study.
    Respir Res. 2016;17:152.
    PubMed     Text format     Abstract available


  49. TERASHITA T, Kobayashi K, Nagano T, Kawa Y, et al
    Administration of JTE013 abrogates experimental asthma by regulating proinflammatory cytokine production from bronchial epithelial cells.
    Respir Res. 2016;17:146.
    PubMed     Text format     Abstract available


    October 2016
  50. TAILLE C, Grootenboer-Mignot S, Estellat C, Roy C, et al
    Perip7lakin is a target for autoimmunity in asthma.
    Respir Res. 2016;17:126.
    PubMed     Text format     Abstract available


  51. SOUTHWORTH T, Plumb J, Gupta V, Pearson J, et al
    Anti-inflammatory potential of PI3Kdelta and JAK inhibitors in asthma patients.
    Respir Res. 2016;17:124.
    PubMed     Text format     Abstract available


    April 2016
  52. HADEBE S, Kirstein F, Fierens K, Redelinghuys P, et al
    beta-Glucan exacerbates allergic airway responses to house dust mite allergen.
    Respir Res. 2016;17:35.
    PubMed     Text format     Abstract available


    March 2016
  53. KOBAYASHI Y, Ito K, Kanda A, Tomoda K, et al
    Protein tyrosine phosphatase PTP-RR regulates corticosteroid sensitivity.
    Respir Res. 2016;17:30.
    PubMed     Text format     Abstract available


    January 2016
  54. BRAIDO F, Brusselle G, Guastalla D, Ingrassia E, et al
    Determinants and impact of suboptimal asthma control in Europe: The INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study.
    Respir Res. 2016;17:51.
    PubMed     Text format     Abstract available


  55. BAKER K, Raemdonck K, Dekkak B, Snelgrove RJ, et al
    Role of the ion channel, transient receptor potential cation channel subfamily V member 1 (TRPV1), in allergic asthma.
    Respir Res. 2016;17:67.
    PubMed     Text format     Abstract available


  56. NASSER S
    An imperfect "PAST" Lessons learned from the National Review of Asthma Deaths (NRAD) UK.
    Respir Res. 2016;17:87.
    PubMed     Text format     Abstract available


  57. EHTESHAMI-AFSHAR S, FitzGerald JM, Carlsten C, Tavakoli H, et al
    The impact of comorbidities on productivity loss in asthma patients.
    Respir Res. 2016;17:106.
    PubMed     Text format     Abstract available


  58. XU D, Wang Y, Chen Z, Li S, et al
    Prevalence and risk factors for asthma among children aged 0-14 years in Hangzhou: a cross-sectional survey.
    Respir Res. 2016;17:122.
    PubMed     Text format     Abstract available


  59. MOHEIMANI F, Hsu AC, Reid AT, Williams T, et al
    The genetic and epigenetic landscapes of the epithelium in asthma.
    Respir Res. 2016;17:119.
    PubMed     Text format     Abstract available


    January 2015
  60. WIECZFINSKA J, Kacprzak D, Pospiech K, Sokolowska M, et al
    The whole - genome expression analysis of peripheral blood mononuclear cells from aspirin sensitive asthmatics versus aspirin tolerant patients and healthy donors after in vitro aspirin challenge.
    Respir Res. 2015;16:147.
    PubMed     Text format     Abstract available


  61. BROWN RH, Reynolds C, Brooker A, Talalay P, et al
    Sulforaphane improves the bronchoprotective response in asthmatics through Nrf2-mediated gene pathways.
    Respir Res. 2015;16:106.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: